In Silico, Ex Vivo and In Vivo Studies of Roflumilast as a Potential Antidiarrheal and Antispasmodic agent: Inhibition of the PDE-4 Enzyme and Voltage-gated Ca++ ion Channels
Other posts you may like
We are now approved with Electronic Catalog (ECAT).
Live Webinar January 21st, 2021 04:00pm GMT / 11:00am EST
January 11-13, 2021 Virtual Event